Hostname: page-component-7bb8b95d7b-nptnm Total loading time: 0 Render date: 2024-10-05T07:54:08.268Z Has data issue: false hasContentIssue false

Can ship travel contain COVID-19 outbreak after re-opening: a Bayesian meta-analysis

Published online by Cambridge University Press:  25 May 2023

Chen-Yang Hsu
Affiliation:
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan Master of Public Health Program, National Taiwan University, Taipei, Taiwan
Jia-Kun Chen
Affiliation:
Institute of Environmental and Occupational Health Sciences, College of Public Health, National Taiwan University, Taipei, Taiwan
Paul S. Wikramaratna
Affiliation:
Independent Consultant, London, England
Amy Ming-Fang Yen
Affiliation:
School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
Sam Li-Sheng Chen
Affiliation:
School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei, Taiwan
Hsiu-Hsi Chen
Affiliation:
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
Chao-Chih Lai*
Affiliation:
Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan Master of Public Health Program, National Taiwan University, Taipei, Taiwan Emergency Department of Taipei City Hospital, Ren-Ai Branch, Taipei, Taiwan
*
Corresponding author: Chao-Chih Lai; Email: chaochin@ms1.hinet.net
Rights & Permissions [Opens in a new window]

Abstract

Large gatherings of people on cruise ships and warships are often at high risk of COVID-19 infections. To assess the transmissibility of SARS-CoV-2 on warships and cruise ships and to quantify the effectiveness of the containment measures, the transmission coefficient (β), basic reproductive number (R0), and time to deploy containment measures were estimated by the Bayesian Susceptible-Exposed-Infected-Recovered model. A meta-analysis was conducted to predict vaccine protection with or without non-pharmaceutical interventions (NPIs). The analysis showed that implementing NPIs during voyages could reduce the transmission coefficients of SARS-CoV-2 by 50%. Two weeks into the voyage of a cruise that begins with 1 infected passenger out of a total of 3,711 passengers, we estimate there would be 45 (95% CI:25-71), 33 (95% CI:20-52), 18 (95% CI:11-26), 9 (95% CI:6-12), 4 (95% CI:3-5), and 2 (95% CI:2-2) final cases under 0%, 10%, 30%, 50%, 70%, and 90% vaccine protection, respectively, without NPIs. The timeliness of strict NPIs along with implementing strict quarantine and isolation measures is imperative to contain COVID-19 cases in cruise ships. The spread of COVID-19 on ships was predicted to be limited in scenarios corresponding to at least 70% protection from prior vaccination, across all passengers and crew.

Type
Original Paper
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Introduction

Large gatherings of people in semiconfined settings, such as on cruise ships and warships, are often at high risk of infections [Reference Kak1]. Previous studies have already shown high attack rates of COVID-19 on cruise ships [Reference Marshall, Morris and Unwin2, Reference Mouchtouri, Verykouki, Zamfir, Hadjipetris, Lewis and Hadjichristodoulou3], where the complex and frequent movements of passengers and high levels of direct and indirect personal contact facilitate the spread of the virus [Reference Zhang, Miao, Huang and Chan4]. The higher population density in these settings renders them susceptible to the quick spread of pathogens harbored in the respiratory tract and digestive lumen [Reference Thomas, Conwill, Morton, Brooks, Holmes and Mahaffey5Reference Bohnker, McEwen, Feeks and Palombaro7].

The first cruise ship to have a major Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) outbreak on board was the Diamond Princess in February 2020 [Reference Yamagishi, Kamiya, Kakimoto, Suzuki and Wakita8] in the wake of the original community-acquired outbreak identified in China in December 2019 [Reference Li, Guan, Wu, Wang, Zhou, Tong, Ren, Leung, Lau, Wong, Xing, Xiang, Wu, Li, Chen, Li, Liu, Zhao, Liu, Tu, Chen, Jin, Yang, Wang, Zhou, Wang, Liu, Luo, Liu, Shao, Li, Tao, Yang, Deng, Liu, Ma, Zhang, Shi, Lam, Wu, Gao, Cowling, Yang, Leung and Feng9, Reference Huang, Wang, Li, Ren, Zhao, Hu, Zhang, Fan, Xu, Gu, Cheng, Yu, Xia, Wei, Wu, Xie, Yin, Li, Liu, Xiao, Gao, Guo, Xie, Wang, Jiang, Gao, Jin, Wang and Cao10]. The first major SARS-CoV-2 outbreak on a naval ship was onboard the Theodore Roosevelt aircraft carrier in March 2020. After these, at least 50 outbreaks occurred during cruise ship voyages, yielding more than 1,100 confirmed cases, and over 20 naval ships, resulting in 2,500 confirmed cases as of March 2021 [11, 12]. Based on these reports, we decided to conduct a systematic review and meta-analysis to elucidate whether the transmissibility of SARS-CoV-2 is heterogeneous across these outbreaks.

Around 30 million people were transported worldwide on cruise ships in 2019, up 6% from 28.2 million in 2018 [Reference Moriarty, Plucinski, Marston, Kurbatova, Knust, Murray, Pesik, Rose, Fitter, Kobayashi, Toda, Cantey, Scheuer, Halsey, Cohen, Stockman, Wadford, Medley, Green, Regan, Tardivel, White, Brown, Morales, Yen, Wittry, Freeland, Naramore, Novak, Daigle, Weinberg, Acosta, Herzig, Kapella, Jacobson, Lamba, Ishizumi, Sarisky, Svendsen, Blocher, Wu, Charles, Wagner, Stewart, Mead, Kurylo, Campbell, Murray, Weidle, Cetron and Friedman13]. Unfortunately, many cruise lines around the world have been suspended, with cruise ships unable to operate during the pandemic for fear of fostering large outbreaks of disease. It is therefore imperative to provide guidance for forestalling COVID-19 outbreaks on cruise ships, and indeed warships, once suspected cases are identified [14]. It is worthy of investigating whether the isolation of suspected cases on board is sufficient to control an outbreak, or if a return to port followed by quarantine on land is necessary, and how these containment measures are potentially affected by vaccination.

Hence, the aims of our study are two-fold. One is to estimate relevant parameters related to the transmissibility of SARS-CoV-2 and examine whether the transmissibility of SARS-CoV-2 on cruise ships and warships was consistent across ship-based outbreaks by pooling multiple data from all outbreaks occurring on board on the basis of meta-analysis. The other is to assess the effectiveness of NPIs (non-pharmaceutical interventions) given different coverage rates of vaccination.

Materials and methods

The data on COVID-19 outbreaks on cruise ships and warships obtained from public messages [15Reference Tate18] and the literature [Reference Oran and Topol19Reference de Laval, Chaudet, Gorgé, Marchi, Lacrosse, Dia, Marbac, Mmadi Mrenda, Texier, Letois, Chapus, Sarilar, Tournier, Levasseur, Cobola, Nolent, Dutasta, Janvier, Meynard and Pommier de Santi25] was used to estimate the parameters of a compartmental model. The characteristics of COVID-19 outbreaks on cruise ships and warships are listed in Table 1. Detailed information about these outbreaks in the six ships enrolled in this study is provided in the Supplementary Table A1.

The Bayesian DAG of meta-analysis with an SEIR model underpinning

To model the dynamics of COVID-19 evolution on each ship, a four-compartment model of susceptible-exposed-infectious-removed (SEIR) was applied. The compartmental model based on the characteristics of COVID-19 is shown in Supplementary Figure A1 with detailed relationships and notations. In brief, the subjects on board were divided into four compartments, namely individuals susceptible to SARS-CoV-2 (S(t)), those exposed and infected but not yet infectious (E(t)), those infectious (I(t)), and those removed from the infectious compartment (R(t)). The S(t), E(t), I(t), and R(t) denote the number of cases at time t. Importantly, we assume that infectious individuals can enter the removal (R) state either because they recover from infection in the traditional sense and become immune or because they are fully and perfectly isolated from the rest of the onboard subjects. Given an effective exposure, the SEIR model assumes that all subjects of the exposed state (E) progress to the infectious state (I). This model was used to evaluate the propagation of SARS-CoV-2 on warships and cruise ships. Based on a previous application of an SEIR model for COVID-19 clustered events on board [Reference Lai, Hsu, Jen, Yen, Chan and Chen24], the propagation of COVID-19 outbreaks on each ship was found to be driven by the transmission coefficient (β), the reciprocal of the infectious period (α), and the recovery rate (σ). Important assumptions in our SEIR model are as follows. (1) All cases in the E state will move into the infectious state by definition because we want to model the undetectable cases for evaluating the effect of NPIs; therefore, all cases of the E state became detectable cases (I+R compartment) later. (2) The E state referred to cases that were initially infected but undetectable (unobserved). If these cases are identified by test or the presence of symptoms, they are then considered to be in an infectious state. A detectable case is defined as an individual who can be identified by a test or by the presence of symptoms during an outbreak. The ratio of symptomatic and pre-symptomatic cases is dependent on the testing strategy used. For example, both were included in the outbreak on Greg Mortimer, whereas only the symptomatic case was included in the outbreaks on the Charles de Gaulle and Theodore Roosevelt aircraft carriers. Therefore, the number of predicted observed cases (detectable cases) was the total number of persons in the I and R compartment. The number of total predicted cases, including undetectable and detectable cases, was the total number of persons in the E, I, and R compartment in this model. (3) We assumed similar transmission probability between symptomatic and asymptomatic cases. (4) Although some crews and passengers left the board in batches without contacting other people after landing, a close population was still considered during the period to stay on board. Therefore, their status still needed to be followed by their testing results. By solving the nonlinear ordinary differential equations of the SEIR model, the expected number of subjects at each compartment can be derived as a function of the three parameters. In addition, we define the time at which containment measures are successful as the time beyond which no member of the S class progresses to the E class. Therefore, the estimated shortest time of successful containment (no member of the S class progresses to the E class) was at the moment the number of final observed cases was within the credible interval (CI) of predicted total cases (E+I+R) in our model.

Stemming from the SEIR model mentioned above, we developed a Bayesian meta-analysis model depicting the COVID-19 outbreak for the six ships enrolled in this study. Figure 1 shows the Bayesian-directed acyclic graphic (DAG) of our meta-analysis model. The observed number of COVID-19 cases on ship k on Day j provides information on the expected numbers of infectious and removed subjects. This information, together with the fixed number of total onboard subjects for ship k, was used for the estimation of the three parameters, β k, α k, and σ k, embedded in the SEIR model. For ships that implemented NPIs, the impact on COVID-19 transmission was captured by the transmission coefficient β’ k. The daily number of COVID-19 cases provides information on the evolution of the four compartments. A normal distribution was applied to capture the expected count of compartments S and E. Regarding the daily count of I and R, one among the normal, binomial, or Poisson distributions was selected depending on the convergence status, by using the trace plot of sampling history [Reference Lai, Hsu, Jen, Yen, Chan and Chen24].

Figure 1. Bayesian DAG of the meta-analysis model for COVID-19 propagation on ships.

Using the Bayesian meta-analysis model, the information on COVID-19 propagation on each type of ship was integrated to derive the posterior information on the distribution of the three main parameters and the effectiveness of NPIs in containing COVID-19 outbreaks on ships. In addition, meta-analyses were also conducted on these outbreaks on cruise ships and warships. We used random effects on the log scale to capture the heterogeneity across ships for each parameter.

While informative priors for the two disease progression parameters βk and αk were used to fit the mean duration from exposure to infectious and from infectious to recovered for 5.25 (95% CI: 4-7) and 7 (95% CI: 5-12) days, respectively, in the COVID-19 outbreak of the Diamond Princess cruise ship [Reference Huang, Wang, Li, Ren, Zhao, Hu, Zhang, Fan, Xu, Gu, Cheng, Yu, Xia, Wei, Wu, Xie, Yin, Li, Liu, Xiao, Gao, Guo, Xie, Wang, Jiang, Gao, Jin, Wang and Cao10, Reference Lai, Hsu, Jen, Yen, Chan and Chen24, Reference Guan, Wang, Yuan, Chen, Ao, Fitzpatrick, Li, Zhou, Lin, Duan, Luo, Fan, Lu, Feng, Zhan, Liang, Cai, Zhang, Du, Li, Shu and Zou26], non-informative priors were used for the transmission coefficient with (βk) and without (βk) NPIs.

To cope with the uncertainty of full joint parameters related to these outbreaks, the Bayesian Markov Chain Monte Carlo (MCMC) was applied to estimate the transmission coefficients, recovery, and incubation rates, and their 95% CI of COVID-19 outbreaks on each ship. The posterior distributions of the common transmission coefficient with (βc) and without (βc) NPIs, and the two disease progression parameters (α c, and σ c) were also derived from the Bayesian meta-analysis model.

With this integrated information on COVID-19 propagation, scenarios of future outbreaks on cruise ships under different conditions, such as with or without the implementation of NPIs or with varying levels of vaccine protection for onboard subjects, can be predicted (right plate, Figure 1). Specifically, we envisaged a cruise ship of the size of the Diamond Princess with a total of 3,711 crews and passengers on board heading for a 14-day voyage, with a single person in the infectious state (I) on initiation of the voyage (Day 0), who was then discovered on Day 7 of the voyage. We then considered how the imposition of NPIs at that point would affect the subsequent size of the outbreak, and additionally assessed the impact of 0%, 10%, 30%, 50%, 70%, and 90% of the ship’s population having been previously successfully vaccinated against SARS-CoV-2, where the influence of vaccine protection was captured by a reduction in transmission coefficient as βc*=βc×(1-Vaccine protection) and βc’*c×(1-Vaccine protection) for the scenario without and with NPIs, respectively. In each case, we used MCMC methods to estimate the final outbreak size and the total number of detectable cases during the voyage if there were 1 or 5 infectious cases boarding these ships initially.

Results

The descriptive characteristics of COVID-19 outbreaks on each of the ships studied here are listed in Table 1. Table 2 shows the results of both parameters, transmission coefficient β (per day) and R0, which were estimated by the Bayesian SEIR model with and without NPIs.

Table 1. Characteristics of COVID-19 outbreaks from empirical data on cruise ships and warships

All passengers wearing surgical masks; The crew with N95 masks for any contact with passengers. NPIs, non-pharmaceutical interventions; PPE, personal protective equipment; R0, basic reproductive number; SEIR model, susceptible-exposed-infected-recovered model.

a Testing after disembarkation.

b Sixty-six suspected COVID-19 cases without laboratory-confirmed infection were not included.

c Testing on voyage.

d 130 asymptomatic cases were found among 1001RT-PCR confirmed cases.

e Testing during onboard quarantine.

f Pre-symptomatic plus symptomatic cases were supposed.

Table 2. Estimated results on parameters for COVID-19 propagation on each ship by using the Bayesian SEIR model

The shortest time of successful containment measures (no member of the S class progresses to the E class): the shortest time while the number of final observed cases was within the CI of predicted total cases (E+I+R). CI, credible interval; R0, basic reproductive number; SEIR model, Susceptible-Exposed-Infected-Recovered model.

Note that the total number of COVID-19 detectable and final cases were predicted by the Bayesian SEIR model (Figure 2(b)(d) and Figure 3; Supplementary Tables C4, C5). The reported and predicted cases by the model in these outbreaks are shown in Figures 2 and 3. The time of disembarking quarantine, such as on the Panshi fast combat support ship, the Charles de Gaulle aircraft carrier, and the Diamond Princess cruise ship, was highly associated with stopping the spread of COVID-19 because the potential cases in the E state and the confirmed cases (I state + R state) at that time were very close to the final size of outbreaks in our model (Table 2). In addition, the date of successful containment was later than the date of disembarking quarantine in the others. So, onboard quarantine alone did not seem sufficient in stopping the spread of COVID-19.

Figure 2. COVID-19 outbreak of warships.

Figure 3. The cumulated COVID-19 observed cases and predicted cases by the Bayesian SEIR model on cruise ships. (R: basic reproductive number).

For cruise ships and warships, both estimates were relatively high with consistent figures ranging from 0.66 (95% CI:0.44-0.91) to 0.92 (95% CI:0.90-0.94) for the transmission coefficient, β (per day), and R0 ranging from 4.62 (95% CI:3.06-6.32) to 6.45 (95% CI:6.24-6.68), without NPIs (Figure 4). The forest plots of the overall effective size of R0 with or without NPIs are shown in Figure 4. The pooled estimates after meta-analysis were 0.79 (95% CI:0.72-0.87) and 5.67 (95% CI:4.74-6.88).

Figure 4. Forest plots for the overall effect of R0 by the Bayesian hierarchical model.

Transmission coefficients and effective reproductive numbers (Rt) of COVID-19 in cruise ships and warships were reduced after the application of NPIs, now ranging from 0.17 (95% CI:0.16-0.19) to 0.69 (95% CI:0.54-0.84) for β and 1.21 (95% CI:1.12-1.30) to 4.87 (95% CI:3.81-5.95) for R0. The pooled estimate for Rt was 1.99 (95% CI:1.09-3.01), which was smaller than that of R0 (Figure 4b).

Effectiveness of NPIs and vaccination

Strict infection-control measures were found to reduce COVID-19 transmission by 57.9% on the Panshi fast combat support ship and by 81.9% on the Theodore Roosevelt aircraft carrier. Meanwhile, according to the transmission coefficients estimated from the meta-analysis, the implementation of NPIs could reduce COVID-19 transmission by 49.5%.

Figure 5 shows the number of COVID-19 detectable cases and predicted total cases under 0%, 10%, 30%, 50%, 70%, and 90% vaccine protection during the voyage of a cruise ship based on 300 simulations from the model posterior. According to the results of the Bayesian hierarchical model (Figure 4a,b), the prior distributions of σ, α, and the logarithm of R0 without or with the control of NPIs were assigned as gamma distribution (shape: 641.5, inverse-scale: 3409), gamma distribution (shape: 649, inverse-scale: 4557), normal distribution (mean: 1.7298, SD:0.0893), and normal distribution (mean: 0.6522, SD: 0.2453), respectively (Figure 5). In the simulation of Bayesian SEIR models with the above-mentioned parameters, there would be 45 (95% CI:25-71), 33 (95% CI:20-52), 18 (95% CI:11-26), 9 (95% CI:6-12), 4 (95% CI:3-5), and 2 (95% CI:2-2) final cases under 0%,10%, 30%, 50%, 70%, and 90% vaccine protection, respectively, without NPIs during the two weeks of the voyage (Supplementary Tables C6–C11). On a 14-day voyage where the first case is only discovered on the 7th day of the voyage, the final size of outbreaks under different vaccine protection scenarios with or without NPIs is shown in Figure 6 (Supplementary Table C12). There would be 17 (95% CI:11-25), 14 (95% CI:9-19), 9 (95% CI:6-11), 5 (95% CI:4-6), 3 (95% CI:2-3), and 2 (95% CI:1-2) final cases under 0%,10%, 30%, 50%, 70%, and 90% vaccine protection, respectively, if NPIs were implemented immediately when symptomatic cases were found on Day 7. In a scenario where all passengers and crew are under at least 70% protection from vaccination, we predicted the total size of a COVID-19 outbreak to be below 5 cases, regardless of whether NPIs are implemented or not on Day 7. The limited spread of COVID-19 (below 5 cases) can be expected under higher levels of vaccine protection even if there is more than 1 infectious case on board at the start of the voyage: for example, our simulated results show how the final size of COVID-19 cases would have been reduced to 3 (95% CI:2-3) had 70% of the passengers and crew been vaccinated compared with the corresponding 17 (95% CI:11-25) cases under the real scenario in the era without vaccination.

Figure 5. Results of COVID-19 detectable cases and predicted total cases under 0%, 10%, 30%, 50%, 70%, and 90% vaccines protection with or without NPI (non-pharmaceutical interventions) when one infectious case boarding ships initially were simulated during the voyage by the Bayesian Markov Chain Monte Carlo (MCMC) method [The “predicted observed cases”, were detectable cases that could be symptomatic or asymptomatic cases, including the I and R compartment in our model. The “total predicted cases” included detectable and undetectable infected cases that became detectable cases later. Hence, our model included them in the E, I, and R compartment.]

Figure 6. The final size of outbreaks under the different vaccine protection with or without NPIs when cases were found on the 7th day of voyage during 14 days voyage.

Discussion

To our knowledge, this is the first comparison of COVID-19 outbreaks on different ships. The R0 of COVID-19 was estimated using data from a series of outbreaks on cruise ships and warships in the Bayesian SEIR model. Onboard quarantine alone did not seem sufficient to stop the spread of COVID-19. Across individual ships, we observed a reduction in COVID-19 transmission from 57.9 to 81.9% under strict infection-control measures. Subject to the assumptions of our meta-analysis, we found that R0 was lowered to around 73% of its original value by the introduction of NPIs on ships.

R0 was estimated as 5.73 for the COVID-19 outbreak on the Diamond Princess cruise ship in this study. This result was similar to previous reports [Reference Zhang, Diao, Yu, Pei, Lin and Chen27Reference Mizumoto and Chowell29] and consistent with other outbreaks on the Grand Princess and Polar expedition cruise ships in our study. We note the high transmissibility of SARS-CoV-2 on the ships in our study and the fact that it may spread via air, droplets, and fomites. Indeed, the persistence of coronaviruses, such as Severe Acute Respiratory Syndrome (SARS) coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus, or endemic human coronaviruses, on inanimate surfaces for up to 9 days has been reported. [Reference Kampf, Todt, Pfaender and Steinmann30] Diarrhea occurred in about 10% of COVID patients [Reference Wang, Hu, Hu, Zhu, Liu, Zhang, Wang, Xiang, Cheng, Xiong, Zhao, Li, Wang and Peng31], and the presence of 2019-nCoV particles in the stool specimens indicates a fecal-oral route for coronavirus, [Reference Wang, Hu, Hu, Zhu, Liu, Zhang, Wang, Xiang, Cheng, Xiong, Zhao, Li, Wang and Peng31, Reference Holshue32] which could account for why it has caused outbreaks on cruise ships with an intensity often seen in the past with gastro-causing norovirus. The fecal spread could present new challenges to the virus’s containment on cruise ships and warships. Environmental decontamination was never mentioned as a precaution taken on any of the ships studied here, and perhaps this could therefore explain why onboard quarantine and isolation alone did not appear sufficient to prevent the further spread of COVID-19 on these ships.

Nevertheless, implementing NPIs during the voyage, such as wearing masks, eating at tables in separate sittings, and isolation of flu-like cases, appeared to substantially reduce COVID-19 transmission in this study. Furthermore, the effectiveness of quarantine and isolation in reducing the number of infected passengers was 37% during the outbreak on the Diamond Princess cruise ship [Reference Lai, Hsu, Jen, Yen, Chan and Chen24]. Strict NPIs, including wearing an N95 mask and full PPE, and the isolation of infected cases, could not, however, stop the transmission of COVID-19 on the Greg Mortimer expedition cruise ship; this may have been due to cross-contamination via the crew’s meal services and other asymptomatic cases, as the rapid antibody testing of COVID-19 patients may have resulted in a high false negative rate in the acute phase. In addition, only testing symptomatic cases and the isolation of them with their contacts was found to be insufficient, because many patients were asymptomatic [Reference Ing, Cocks and Green23]. Furthermore, quarantine aboard the Panshi fast combat support ship for a period of 6 days before disembarkation (9–15 April) seems to not have prevented the spread of COVID-19 onboard the ship.

Asymptomatic cases may be the potential sources of SARS-CoV-2 infection and the key to controlling outbreaks. In addition, asymptomatic SARS-CoV-2 transmission with high viral load has been reported [Reference Rothe, Schunk, Sothmann, Bretzel, Froeschl, Wallrauch, Zimmer, Thiel, Janke, Guggemos, Seilmaier, Drosten, Vollmar, Zwirglmaier, Zange, Wölfel and Hoelscher33]. Under the assumption of the same transmission probability between symptomatic and asymptomatic cases, our SEIR model fitted well to data from different outbreaks on cruise ships and warships. The fraction of pre-symptomatic transmission events out of pre-symptomatic plus symptomatic transmission events was 37% [95% confidence interval (CI), 27.5 to 45%] in a previous study [Reference Ferretti, Wymant, Kendall, Zhao, Nurtay, Abeler-Dörner, Parker, Bonsall and Fraser34]. High proportions of asymptomatic cases were found in outbreaks on ships, which may result from a higher proportion of latent cases. Therefore, COVID-19 continues to spread during the onboard quarantine period because these asymptomatic cases cannot be easily detected and the universal testing of all passengers and crew was rarely performed.

The cruise industry has been severely hit by the impact of COVID-19 as a major outbreak could potentially be triggered during cruise ship voyages. Even if the vaccine coverage rate was 100% among the passengers and crew, the effectiveness of a 2-dose messenger RNA (mRNA) or adenovirus-vectored COVID-19 vaccine will be imperfect and is likely to wane over time and in the face of new variants of SARS-CoV-2 [Reference Gupta and Topol35, Reference Pegu36]. This study introduces some frameworks to allow the resumption of the cruise industry in the post-COVID-19 era. For example, if one asymptomatic COVID-19 person boards the cruise ship for a two-week trip and there is greater than 70% vaccine protection among the passengers and crews, then our simulation results suggest that even without NPIs there will be only limited COVID-19 cases during such a voyage. Furthermore, it appears that it may be possible to readily control the spread of COVID-19 on a cruise ship that has more than 90% vaccine protection among passengers and crew even if 5 infectious cases board the cruise ship. However, new strains of SARS-CoV2 have developed, which has led to even high vaccine coverage providing only limited protection from infection. Hence, it might seem prudent that NPIs should still be implemented immediately when any new case arising from new subvariants emerges in the post-COVID-19 pandemic era. In addition, full disembarkation and quarantine should be considered because onboard isolation and quarantine alone do not appear to be enough to stop the spread of COVID-19.

There were some limitations to our modelling and estimates of the R0 of COVID-19, most obviously the assumptions of a close population even with leaving the board in batches, a homogeneous random mixing population, and no difference of transmission probability between symptomatic and asymptomatic cases. The estimated results on the transmission parameters for the Grand Princess cruise ship may be biased towards underestimation because not everyone on board was tested [Reference Guagliardo, Prasad, Rodriguez, Fukunaga, Novak, Ahart, Reynolds, Griffin, Wiegand, Quilter, Morrison, Jenkins, Wall, Treffiletti, White, Regan, Tardivel, Freeland, Brown, Wolford, Johansson, Cetron, Slayton and Friedman37]. In addition, the basic and effective reproductive number may be underestimated because only the final detectable cases were modelled, which is affected by the different testing strategies. All undetectable cases, such as asymptomatic cases without receiving testing, did not enter the infectious state in this study. However, consistent results were obtained from the different outbreaks under consideration. Most of the outbreaks that took place on cruise ships and warships were reported during the Wuhan strain and the Alpha VOC period. Furthermore, only the aggregate data on the number of cases that evolved through the clustered event without detailed information on the history of previous infections were available. The evaluation of the protective effectiveness derived from the infection by ancestral strains was thus hampered. In addition, potential changes in the reproduction number of SARS-CoV-2 variants [Reference Campbell, Archer, Laurenson-Schafer, Jinnai, Konings, Batra, Pavlin, Vandemaele, Van Kerkhove, Jombart, Morgan and le Polain de Waroux38] are not considered in our model. However, as the omicron variants and subvariants had higher transmissibility and immune escape than the ancestral strain [Reference Willett39], and vaccination protection against emerging variant strains may not be desirable due to weaning immunity. The effectiveness of the vaccine against omicron infections may be reduced compared to its effectiveness against the previous strains. Hence, the results of our simulation will be the best scenarios for predicting the future challenges in the post-COVID-19 pandemic era. However, given a body of evidence indicating an enhanced and long-lasting immune response built on hybrid immunity [Reference Goldberg40], passengers and crew who have recovered from previous infections with updated vaccination status can further secure the safety on board in terms of the risk of the COVID-19 outbreak.

In conclusion, we find a limited spread of SARS-CoV-2 during the two weeks of a voyage under at least over 70% of vaccine protection with NPIs. Usage of masks by the crew for any contact with passengers is advisable. Furthermore, testing of symptomatic cases and their contacts, disembarkation quarantine, and the isolation of symptomatic/ asymptomatic cases should nevertheless be performed as soon as possible when COVID-19 cases are found on ships, because of the high proportion of asymptomatic/pre-symptomatic cases likely to be present. Of course, a higher rate of updated vaccine protection among the crew and passengers is also necessary for stopping the spread of COVID-19 on cruise ships.

Supplementary material

The supplementary material for this article can be found at https://doi.org/10.1017/S0950268823000821.

Data availability statement

The data that support the findings of this study are openly available in the public domain and in the literature [15Reference de Laval, Chaudet, Gorgé, Marchi, Lacrosse, Dia, Marbac, Mmadi Mrenda, Texier, Letois, Chapus, Sarilar, Tournier, Levasseur, Cobola, Nolent, Dutasta, Janvier, Meynard and Pommier de Santi25]. They are listed in the Supplementary material.

Acknowledgments

This study was funded by the Ministry of Science and Technology, Taiwan (MOST 109-2327-B-002-009). The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author contribution

C-Y.H., J-K.C., P.S.W., and C-C.L. contributed to the study conception/design. C-Y.H. and J-K.C. took responsibility of drafting the manuscript. C-Y.H., J-K.C., and C-C.L. took responsibility of the statistical analysis. M-F.Y., S.L-S.C., and H-H.C. contributed to the study conception and the accuracy of the data analysis. P.S.W., H-H.C., and C-C.L. reviewed and revised the article.

Competing interest

The authors declare none.

Footnotes

C.Y.H. and J.K.C. contributed equally.

References

Kak, V (2007) Infections in confined spaces: Cruise ships, military barracks, and college dormitories. Infectious Disease Clinics of North America 21(3), 773784, ix-x.CrossRefGoogle ScholarPubMed
Marshall, CA, Morris, E and Unwin, N (2016) An epidemiological study of rates of illness in passengers and crew at a busy Caribbean cruise port. BMC Public Health 16, 314.CrossRefGoogle Scholar
Mouchtouri, VA, Verykouki, E, Zamfir, D, Hadjipetris, C, Lewis, HC, Hadjichristodoulou, C and EU SHIPSAN ACT Partnership (2017) Gastroenteritis outbreaks on cruise ships: Contributing factors and thresholds for early outbreak detection. Euro Surveillance 22(45), 16-00576.Google ScholarPubMed
Zhang, N, Miao, R, Huang, H and Chan, E (2016) Contact infection of infectious disease onboard a cruise ship. Scientific Reports 6, 38790.CrossRefGoogle ScholarPubMed
Thomas, RJ, Conwill, DE, Morton, DE, Brooks, TJ, Holmes, CK and Mahaffey, WB (1988) Penicillin prophylaxis for streptococcal infections in United States navy and marine corps recruit camps, 1951-1985. Reviews of Infectious Diseases 10(1), 125130.CrossRefGoogle ScholarPubMed
Sharp, TW, Hyams, KC, Watts, D, Trofa, AF, Martin, GJ, Kapikian, AZ, Green, KY, Jiang, X, Estes, MK and Waack, M (1995) Epidemiology of Norwalk virus during an outbreak of acute gastroenteritis aboard a US aircraft carrier. Journal of Medical Virology 45(1), 6167.CrossRefGoogle ScholarPubMed
Bohnker, B, McEwen, G, Feeks, E and Palombaro, J (1993) Explosive outbreak of gastroenteritis on an aircraft carrier: An infectious disease mass casualty situation. Aviation Space and Environmental Medicine 64(7), 648650.Google Scholar
Yamagishi, T, Kamiya, H, Kakimoto, K, Suzuki, M and Wakita, T (2020) Descriptive study of COVID-19 outbreak among passengers and crew on diamond princess cruise ship, Yokohama Port, Japan, 20 January to 9 February 2020. Euro Surveillance 25(23), 2000272.Google ScholarPubMed
Li, Q, Guan, X, Wu, P, Wang, X, Zhou, L, Tong, Y, Ren, R, Leung, KSM, Lau, EHY, Wong, JY, Xing, X, Xiang, N, Wu, Y, Li, C, Chen, Q, Li, D, Liu, T, Zhao, J, Liu, M, Tu, W, Chen, C, Jin, L, Yang, R, Wang, Q, Zhou, S, Wang, R, Liu, H, Luo, Y, Liu, Y, Shao, G, Li, H, Tao, Z, Yang, Y, Deng, Z, Liu, B, Ma, Z, Zhang, Y, Shi, G, Lam, TTY, Wu, JT, Gao, GF, Cowling, BJ, Yang, B, Leung, GM and Feng, Z (2020) Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine 382(13), 11991207.CrossRefGoogle ScholarPubMed
Huang, C, Wang, Y, Li, X, Ren, L, Zhao, J, Hu, Y, Zhang, L, Fan, G, Xu, J, Gu, X, Cheng, Z, Yu, T, Xia, J, Wei, Y, Wu, W, Xie, X, Yin, W, Li, H, Liu, M, Xiao, Y, Gao, H, Guo, L, Xie, J, Wang, G, Jiang, R, Gao, Z, Jin, Q, Wang, J and Cao, B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223), 497506.CrossRefGoogle ScholarPubMed
Anon COVID-19 pandemic on cruise ships. Available at https://en.wikipedia.org/wiki/COVID-19_pandemic_on_cruise_ships (accessed 20 November 2021).Google Scholar
Anon COVID-19 pandemic on naval ships. Available at https://en.wikipedia.org/wiki/COVID-19_pandemic_on_naval_ships#Summary_of_confirmed_cases (accessed 20 November 2021).Google Scholar
Moriarty, LF, Plucinski, MM, Marston, BJ, Kurbatova, EV, Knust, B, Murray, EL, Pesik, N, Rose, D, Fitter, D, Kobayashi, M, Toda, M, Cantey, PT, Scheuer, T, Halsey, ES, Cohen, NJ, Stockman, L, Wadford, DA, Medley, AM, Green, G, Regan, JJ, Tardivel, K, White, S, Brown, C, Morales, C, Yen, C, Wittry, B, Freeland, A, Naramore, S, Novak, RT, Daigle, D, Weinberg, M, Acosta, A, Herzig, C, Kapella, BK, Jacobson, KR, Lamba, K, Ishizumi, A, Sarisky, J, Svendsen, E, Blocher, T, Wu, C, Charles, J, Wagner, R, Stewart, A, Mead, PS, Kurylo, E, Campbell, S, Murray, R, Weidle, P, Cetron, M, Friedman, CR, CDC Cruise Ship Response Team, California Department of Public Health COVID-19 Team and Solano County COVID-19 Team (2020) Public health responses to COVID-19 outbreaks on cruise ships - worldwide, February-March 2020. MMWR Morbidity and Mortality Weekly Report 69(12), 347352.CrossRefGoogle ScholarPubMed
Anon COVID-19 pandemic on USS Theodore Roosevelt. Available at https://en.wikipedia.org/wiki/COVID-19_pandemic_on_USS_Theodore_Roosevelt (accessed 27 June 2020).Google Scholar
Gros-Verheyde N. Covid-19 (2020) Did Belgium make the right choice by interrupting the Foch mission In.Google Scholar
Tate, C (2020) Some Grand Princess cruise passengers waited weeks for coronavirus test results, or never got tested. USA Today. Available at https://www.usatoday.com/story/travel/cruises/2020/04/20/grand-princess-cruisers-waited-weeks-coronavirus-test-results/5162904002/ (accessed 27 June 2020).Google Scholar
Oran, DP and Topol, EJ (2021) Prevalence of asymptomatic SARS-CoV-2 infection: A narrative review. Annals of Internal Medicine. 174(2):286-287CrossRefGoogle Scholar
Peniston, B The Battle of USS Theodore Roosevelt: A Timeline. Available at https://www.defenseone.com/threats/2020/04/timeline-battle-uss-theodore-roosevelt/164408/ (accessed 27 June 2020).Google Scholar
Kasper, MR, Geibe, JR, Sears, CL, Riegodedios, AJ, Luse, T, Von Thun, AM, McGinnis, MB, Olson, N, Houskamp, D, Fenequito, R, Burgess, TH, Armstrong, AW, DeLong, G, Hawkins, RJ and Gillingham, BL (2020) An outbreak of Covid-19 on an aircraft carrier. The New England Journal of Medicine 383(25), 24172426.CrossRefGoogle Scholar
Kakimoto, K, Kamiya, H, Yamagishi, T, Matsui, T, Suzuki, M and Wakita, T (2020 ) Initial investigation of transmission of COVID-19 among crew members during quarantine of a cruise ship - Yokohama, Japan, February 2020. MMWR Morbidity and Mortality Weekly Report 69(11), 312313.CrossRefGoogle ScholarPubMed
Ing, AJ, Cocks, C and Green, JP (2020) COVID-19: In the footsteps of Ernest Shackleton. Thorax 75, 693694.CrossRefGoogle ScholarPubMed
Lai, CC, Hsu, CY, Jen, HH, Yen, AMF, Chan, CC and Chen, HH (2021) The Bayesian susceptible-exposed-infected-recovered model for the outbreak of COVID-19 on the diamond princess cruise ship. Stochastic Environmental Research and Risk Assessment 35, 13191333.CrossRefGoogle ScholarPubMed
de Laval, F, Chaudet, H, Gorgé, O, Marchi, J, Lacrosse, C, Dia, A, Marbac, V, Mmadi Mrenda, B, Texier, G, Letois, F, Chapus, C, Sarilar, V, Tournier, JN, Levasseur, A, Cobola, J, Nolent, F, Dutasta, F, Janvier, F, PA-CDG COVID-19 Investigation Group, Meynard, JB and Pommier de Santi, V (2022) Investigation of a COVID-19 outbreak on the Charles de Gaulle aircraft carrier, March to April 2020: A retrospective cohort study. Euro Surveillance 27(21), 2100612.Google Scholar
Guan, WJ, Wang, B, Yuan, T, Chen, X, Ao, Y, Fitzpatrick, T, Li, P, Zhou, Y, Lin, YF, Duan, Q, Luo, G, Fan, S, Lu, Y, Feng, A, Zhan, Y, Liang, B, Cai, W, Zhang, L, Du, X, Li, L, Shu, Y and Zou, H (2020) Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine 382(18), 17081720.CrossRefGoogle ScholarPubMed
Zhang, S, Diao, M, Yu, W, Pei, L, Lin, Z and Chen, D (2020) Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the diamond princess cruise ship: A data-driven analysis. International Journal of Infectious Diseases 93, 201204.CrossRefGoogle Scholar
Rocklov, J, Sjodin, H and Wilder-Smith, A (2020) COVID-19 outbreak on the diamond princess cruise ship: Estimating the epidemic potential and effectiveness of public health countermeasures. Journal of Travel Medicine 27(3), taaa030.CrossRefGoogle ScholarPubMed
Mizumoto, K and Chowell, G (2020) Transmission potential of the novel coronavirus (COVID-19) onboard the diamond princess cruises ship, 2020. Infectious Disease Modelling 5, 264270.CrossRefGoogle ScholarPubMed
Kampf, G, Todt, D, Pfaender, S and Steinmann, E (2020) Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. Journal of Hospital Infection 104(3), 246251.CrossRefGoogle ScholarPubMed
Wang, D, Hu, B, Hu, C, Zhu, F, Liu, X, Zhang, J, Wang, B, Xiang, H, Cheng, Z, Xiong, Y, Zhao, Y, Li, Y, Wang, X and Peng, Z (2020) Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. The Journal of the American Medical Association 323(11), 10611069.CrossRefGoogle ScholarPubMed
Holshue, Michelle L, et al. (2020) First case of 2019 novel coronavirus in the United States. The New England Journal of Medicine 382(10), 929936.CrossRefGoogle Scholar
Rothe, C, Schunk, M, Sothmann, P, Bretzel, G, Froeschl, G, Wallrauch, C, Zimmer, T, Thiel, V, Janke, C, Guggemos, W, Seilmaier, M, Drosten, C, Vollmar, P, Zwirglmaier, K, Zange, S, Wölfel, R and Hoelscher, M (2020) Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. The New England Journal of Medicine 382(10), 970971.CrossRefGoogle ScholarPubMed
Ferretti, L, Wymant, C, Kendall, M, Zhao, L, Nurtay, A, Abeler-Dörner, L, Parker, M, Bonsall, D and Fraser, C (2020) Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science 368(6491), eabb6936.CrossRefGoogle ScholarPubMed
Gupta, RK and Topol, EJ (2021) COVID-19 vaccine breakthrough infections. Science 374(6575), 15611562.CrossRefGoogle ScholarPubMed
Pegu, A, et al. (2021) Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science 373(6561), 13721377.CrossRefGoogle ScholarPubMed
Guagliardo, SAJ, Prasad, PV, Rodriguez, A, Fukunaga, R, Novak, RT, Ahart, L, Reynolds, J, Griffin, I, Wiegand, R, Quilter, LAS, Morrison, S, Jenkins, K, Wall, HK, Treffiletti, A, White, SB, Regan, J, Tardivel, K, Freeland, A, Brown, C, Wolford, H, Johansson, MA, Cetron, MS, Slayton, RB and Friedman, CR (2022) Cruise ship travel in the era of COVID-19: A summary of outbreaks and a model of public health interventions. Clinical Infectious Diseases 74, 490497.CrossRefGoogle Scholar
Campbell, F, Archer, B, Laurenson-Schafer, H, Jinnai, Y, Konings, F, Batra, N, Pavlin, B, Vandemaele, K, Van Kerkhove, MD, Jombart, T, Morgan, O and le Polain de Waroux, O (2021) Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021. Euro Surveillance 26(24), 2100509.Google ScholarPubMed
Willett, BJ, et al. (2022) SARS-CoV-2 omicron is an immune escape variant with an altered cell entry pathway. Nature Microbiology 7(8), 11611179.CrossRefGoogle ScholarPubMed
Goldberg, Y, et al. (2022) Protection and waning of natural and hybrid immunity to SARS-CoV-2. The New England Journal of Medicine 386(23), 22012212.CrossRefGoogle ScholarPubMed
Figure 0

Figure 1. Bayesian DAG of the meta-analysis model for COVID-19 propagation on ships.

Figure 1

Table 1. Characteristics of COVID-19 outbreaks from empirical data on cruise ships and warships

Figure 2

Table 2. Estimated results on parameters for COVID-19 propagation on each ship by using the Bayesian SEIR model

Figure 3

Figure 2. COVID-19 outbreak of warships.

Figure 4

Figure 3. The cumulated COVID-19 observed cases and predicted cases by the Bayesian SEIR model on cruise ships. (R: basic reproductive number).

Figure 5

Figure 4. Forest plots for the overall effect of R0 by the Bayesian hierarchical model.

Figure 6

Figure 5. Results of COVID-19 detectable cases and predicted total cases under 0%, 10%, 30%, 50%, 70%, and 90% vaccines protection with or without NPI (non-pharmaceutical interventions) when one infectious case boarding ships initially were simulated during the voyage by the Bayesian Markov Chain Monte Carlo (MCMC) method [The “predicted observed cases”, were detectable cases that could be symptomatic or asymptomatic cases, including the I and R compartment in our model. The “total predicted cases” included detectable and undetectable infected cases that became detectable cases later. Hence, our model included them in the E, I, and R compartment.]

Figure 7

Figure 6. The final size of outbreaks under the different vaccine protection with or without NPIs when cases were found on the 7th day of voyage during 14 days voyage.

Supplementary material: File

Hsu et al. supplementary material

Hsu et al. supplementary material

Download Hsu et al. supplementary material(File)
File 1.3 MB